Literature DB >> 10078995

Relationship among cholesterol, superoxide anion and endothelium-dependent relaxation in diabetic rats.

T Kobayashi1, K Kamata.   

Abstract

The purpose of the present study was to investigate the time course of changes in plasma low-density lipoprotein (LDL) cholesterol, tissue lipid peroxidation, the expression of hepatic LDL-receptor mRNA and aortic superoxide dismutase, and the relaxation response to acetylcholine in streptozotocin-induced diabetic rats. Plasma cholesterol and LDL levels were significantly increased in both 4- and 10-week diabetic rats. The tissue malonic dialdehyde content in aortas was increased in 10-week compared to 1- or 4-week diabetic rats. The expression of mRNA for LDL receptor mRNA in the liver showed a decrease in both 4- and 10-week diabetic rats. Hepatic LDL-receptor binding activity decreased significantly in 10-week diabetic rats, and decreased binding activity in diabetic rats was improved by the chronic administration of cholestyramine. The relaxation responses to acetylcholine in helical strips of the aorta precontracted with noradrenaline were significantly decreased in 10-week, but not in 1- or 4-week streptozotocin-induced diabetic rats. The decreased relaxation response to acetylcholine was improved by chronic cholestyramine. Both the expression of Mn-superoxide dismutase mRNA and the activity of superoxide dismutase in the aorta were decreased in 10-week, but not in 4-week diabetic rats. From time-course studies, our data suggest that not only increased LDL cholesterol but also decreased activity of superoxide dismutase are responsible for the decreased relaxation response induced by acetylcholine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10078995     DOI: 10.1016/s0014-2999(98)00971-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide.

Authors:  N R F Nascimento; L M A Lessa; M R Kerntopf; C M Sousa; R S Alves; M G R Queiroz; J Price; D B Heimark; J Larner; X Du; M Brownlee; A Gow; C Davis; M C Fonteles
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-22       Impact factor: 11.205

2.  Mechanisms underlying the attenuation of endothelium-dependent vasodilatation in the mesenteric arterial bed of the streptozotocin-induced diabetic rat.

Authors:  A Makino; K Ohuchi; K Kamata
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

3.  Role of endothelium-dependent hyperpolarisation and prostacyclin in diabetes.

Authors:  Siti Safiah Mokhtar; Aida Hanum Ghulam Rasool
Journal:  Malays J Med Sci       Date:  2015 Mar-Apr

4.  Effects of chronic administration of the novel endothelin antagonist J-104132 on endothelial dysfunction in streptozotocin-induced diabetic rat.

Authors:  Noriyasu Kanie; Katsuo Kamata
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

5.  Phosphatidylinositol 3-kinase-δ up-regulates L-type Ca2+ currents and increases vascular contractility in a mouse model of type 1 diabetes.

Authors:  J F Pinho; M A A Medeiros; L S A Capettini; B A Rezende; P P Campos; S P Andrade; S F Cortes; J S Cruz; V S Lemos
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

6.  Relationship between peroxisome proliferator-activated receptors (PPAR alpha and PPAR gamma) and endothelium-dependent relaxation in streptozotocin-induced diabetic rats.

Authors:  Noriyasu Kanie; Takayuki Matsumoto; Tsuneo Kobayashi; Katsuo Kamata
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

7.  Differential changes of aorta and carotid vasodilation in type 2 diabetic GK and OLETF rats: paradoxical roles of hyperglycemia and insulin.

Authors:  Mei-Fang Zhong; Wei-Li Shen; Masaki Tabuchi; Kyoko Nakamura; Yi-Chen Chen; Cong-Zhen Qiao; Jin He; Jie Yang; Chuan Zhang; Zdravko Kamenov; Hideaki Higashino; Hong Chen
Journal:  Exp Diabetes Res       Date:  2011-10-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.